Anti-inflammatory strategies for atherosclerotic artery disease.

The main challenge associated with specific anti-inflammatory drugs is the risk of immunological suppression. Due to positive results in recent randomized trials and a favorable safety profile, colchicine is expected to gain more popularity in the near future as an anti-inflammatory agent for cardiovascular prevention.